Investors

BUSINESS FOCUS & GROWTH STRATEGY

Zim focuses on multiple business aspects & multi-pronged growth strategy for sustained progress.

FINANCIALS

NET SALES

India Sales (Rs. Crore)

Net Profit (Rs. Crore)

US Sales ($ Million)

Earning per Share (Rs. Crore)

Rest of the World Sales ($ Million)

ANNUAL REPORTS & PRESENTATIONS

INVESTOR PRESENTATIONS
2017-18 ANNUAL REPORT
2016-17 ANNUAL REPORT
2015-16 ANNUAL REPORT
2014-15 ANNUAL REPORT
2013-14 ANNUAL REPORT

ANNUAL REPORT OF SUBSIDIARY COMPANIES

SHAREHOLDER'S INFORMATION

Dear Shareholders,

As you may be aware, the Ministry of Corporate Affairs (MCA) on May 10, 2012 notified the IEPF (Uploading of information regarding unpaid and unclaimed amounts lying with companies) Rules, 2012 (IEPF Rules), which is applicable to your Corporation.

The objective of the IEPF Rules is to help you ascertain status of the unclaimed amounts and overcome the problems due to misplacement of intimation thereof by post etc.

In terms of the said IEPF Rules, your Corporation has uploaded the following information in respect of the unclaimed dividends, unclaimed deposit and interest accrued thereon in respect of the financial years 2004-05 up to 2010-11, on the websites of the IEPF viz. www.iepf.gov.in and the Corporation viz. www.zimlab.in.

Search Unclaimed Dividends

2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2018

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

2017

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

2016

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

2015

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

2014

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

2013
2012

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

2011

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

Notice of Board meeting - Nov 13, 2018

Outcome of Board meeting - Nov 13, 2018

Intimation regarding inter-se change in shareholding of promoter group pursuant to Scheme of Amalgamation.

Complaint Report filed by the Company to National Stock Exchange of India Limited pursuant to filing of Draft Scheme of Arrangement

Complaint Report filed by the Company to BSE Limited pursuant to filing of Draft Scheme of Arrangement

2010
2009
2008
Dividend Calculator
Share Price
Dividend Calculator

Use this tool to view Zim Lab's dividend history and look up your past dividend payments


The Dividend per share (R) :


Share Price

Use this tool to calculate the value of your Zim Labs stockholding today

Current Value Calculator

I own share(s) valued at (R) 519.6 per share. (share price as of 18 November 2018). Current Value 0.00 (R).

Historic Share Price Calculator

I purchased share(s) on

DETAILS OF EQUITY SHARES LIABLE FOR TRANSFER TO IEPF

DETAILS OF EQUITY SHARES TRANSFERRED TO IEPF

CONTACT FORM






Please answer the simple math problem below. This is to prevent automated spam.



CORPORATE OFFICE

ZIM Laboratories Limited
SUN HOUSE,
CTS No. 201 B/1,
Western Express Highway,
Goregaon (E),
Mumbai 400063
Tel : (+91 22) 4324 4324
Fax : (+91 22) 4324 4343

INVESTOR CONTACT

Registrars & Transfer Agent:
Link Intime India Private Limited,
Unit: Sun Pharmaceutical Industries Limited,
C 101, 247 Park, L.B.S. Marg,
Vikhroli West,
Mumbai (INDIA) - 400083

Tel. No.: +91 22 49186270 / +91 22 49186000
Fax No.: +91 22 49186060
E-Mail: rnt.helpdesk@linkintime.co.in / sunpharma@linkintime.co.in

Individual Investors & Queries Related to Shares/Dividend, etc. 
Secretarial Department
SUN HOUSE, CTS No. 201 B/1,
Western Express Highway,
Goregaon (E), Mumbai 400063
Telephone: (+91 22) 4324 4324
Email : secretarial@sunpharma.com

Institutional Investors
Nimish Desai
SUN HOUSE, CTS No. 201 B/1,
Western Express Highway,
Goregaon (E), Mumbai 400063
Telephone: (+91 22) 4324 4324
Email : nimish.desai@sunpharma.com

Nodal Officer
(for the purpose of IEPF)
Ashok I. Bhuta
Email: mail@xample.com

MEDIA CONTACT

GAURAV CHUGH
SUN HOUSE, CTS No. 201 B/1,
Western Express Highway,
Goregaon (E),
Mumbai 400063
Telephone: (+91 22) 4324 4324
Email : gaurav.chugh@sunpharma.com

ADVERSE EVENT REPORTING 

Global Pharmacovigilance Department
Sun Pharmaceutical Industries Ltd.
SUN HOUSE,
CTS No. 201 B/1,
Western Express Highway,
Goregaon (E),
Mumbai 400063
Tel : (+91 22) 4324 4324
Fax : +91-22-66455699
E-Mail: example@mail.com

Please click here to fill an online adverse event reporting form

zim laboratories ltd

Sun Pharma Laboratories Limited (“SPLL” or “Company”) is a pharmaceutical company having registered office in Mumbai, Maharashtra. The Company manufactures and markets pharmaceutical products in India. It was incorporated on January 17, 1997. On March 9, 2012, it became a wholly owned subsidiary of Sun Pharmaceutical Industries Limited (SPIL). The Domestic Formulation Undertaking of SPIL was transferred to the Company with effect from March 31, 2012, pursuant to the Scheme of Arrangement between Sun Pharmaceutical Industries Limited and the Company. The shares of the Company are not listed on any of the Stock Exchanges.

SPLL is engaged in the business of manufacturing and promoting Branded Generic pharmaceutical products and has a market share of 5.6% as per AIOCD AWACS ‐October 2015. The Company has four plants located in Sikkim and Jammu. It has strong foothold in the therapeutic segments of Neurology & Psychiatry, Central Nervous System, Cardiology, Gastroenterology, Diabetes, Gynecology etc. The Company is a market leader in India in the chronic segment, which contributes over 60% of its revenue as per AIOCD AWACS ‐October 2015. It offers a complete therapy basket with specialization in technically complex products. Among the country’s top 300 pharmaceutical brands, SPLL owns 19 brands. It has a strong field force of over 3,200 people who promote products to over 150,000 doctors across India. The field force has well-trained sales representatives with a strong track record of performance and enjoys one of the highest productivity amongst Indian pharmaceutical companies. The Company has consistently outperformed the average industry growth over years. As per February 2015 SMSRC report, the Company was ranked No.1 by prescriptions with 7 class of specialist doctors.

I am raw html block.
Click edit button to change this html

Anuall Reports

ZLL 2017-18

ZLL 2016-17

ZLL 2015-16

ZLL 2014-15

Financial Results submitted to the Exchange

Financial Results for the Half Year ended 30.09.2018

Financial Results for the half year and year ended on 31.03.2018

Financial Results for the half year and year ended on 31.03.2018

Financial Results for the half year and year ended on 31.03.2018

Financial Results for the half year and year ended on 31.03.2018

Financial Results for the half year and year ended on 31.03.2018

Financial Results for the half year and year ended on 31.03.2018

SPLL 2016-17

SPLL 2016-17

SPLL 2016-17

Compliance Officer

Rachana Kokal
Sun House, Plot No. 201 B/1, Western Express Highway,
Goregaon East, Mumbai, Maharashtra (India) ‐ 400 063
Contact No: 022-4324 4324
Fax No: 022-4324 4343


Registrar & Transfer Agent:

Link Intime (India) Private Limited
C-13, Pannalal Silk Mills Compound, L.B.S. Marg,
Bhandup (West),Mumbai – 400078
Contact No: 022-25946970
Fax No: 022-25946969


Debenture Trustee
Axis Trustee Services Limited
Axis House, 2nd Floor,
Wadia International Centre,
Pandurang Budhkar Marg,
Worli, Mumbai 400025
Tel. No.: 022 24255215
Fax No.: 022 43253000

INVESTOR CONTACT

MR. PIYUSH NIKHADE

Sadoday Gyan (Ground Floor)

Opp. NADT, Nelson Square,

Nagpur – 440013

 cs@zimlab.in  0712-2588070